Brief: Aridis Pharmaceuticals Notified Of Terminated License Agreement With Medimmune

Aridis Pharmaceuticals

29/03/2023 11:14

March 29 (Reuters) - Aridis Pharmaceuticals Inc
 ARDS.O :
    * ARIDIS PHARMACEUTICALS - ON MARCH 20, GOT WRITTEN NOTICE
FROM
MEDIMMUNE LIMITED THAT IT HAS TERMINATED LICENSE AGREEMENT DATED
AS OF JULY 12, 2021
    * ARIDIS PHARMACEUTICALS INC - NOTICE STATES THAT SUCH
TERMINATION
SHALL BE EFFECTIVE ON MARCH 30
    * ARIDIS PHARMACEUTICALS INC - AS RESULT OF TERMINATION
NOTICE,
ON-GOING AR-320-003 PHASE 3 CLINICAL STUDY MUST BE PUT ON HOLD
    * ARIDIS PHARMACEUTICALS INC - DOES NOT AGREE THAT IT IS IN
MATERIAL BREACH OF LICENSE AGREEMENT

Source text for Eikon:  ID: 
Further company coverage:  ARDS.O 

 ((Reuters.Briefs@thomsonreuters.com;))